shutterstock_607718810

ABOUT

IMMUNO CURE

Immuno Cure is a biotechnology group based in the Hong Kong Science Park, focusing on research and development of immunotherapies for cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA vaccine and Anti-Δ42PD1 Antibody Immune Blockade technology platforms.

Learn More

OUR

TEAM

More Detail
Dr. Percy Cheng

Dr. Percy CHENG 

MH 
(Co-Founder)

Executive Director
Chairman of the Board

Jin Xia_photo window background_tuned final 2

Dr. Xia JIN

(Co-Founder)

Executive Director

Chief Executive Officer

Andy Wong

Mr. Andy WONG

(Co-Founder)

Executive Director

 

Peter Tang

Mr. Peter TANG

(Co-Founder)

Executive Director

Dr. Leong

Dr. Che Hung LEONG, Edward

GBM, GBS, OBE, JP

Chairman of Advisory Board

Dr. Ko

Dr. Wing Man KO

GBS, JP

Advisory Board Member

Dr. David Ho

Dr. Da I HO, David

Advisory Board Member

Prof Chen

Prof. Zhiwei CHEN

(Co-Founder)

Advisory Board Member

and Principal Scientific Advisor

Mr. Tom Lau

Mr. Tom LAU

(Co-Founder)

Director of Corporate Finance

Michael Wong

Dr. Michael WONG

Research and Development Director

Dr. Wai Sing Fai

Dr. Sing Fai WAI

Chief Technology Officer

David Du

Mr. David Yanhua DU

General Manager of

Shenzhen Immuno Cure

Wang Ting

Ms. Ting WANG

Clinical and Regulatory Director

DNA VACCINE

PLATFORM

Learn More

ANTI-Δ42PD1

ANTIBODY PLATFORM

Learn More
pipeline-photo

PIPELINE

Learn More